Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... Some Diabetes Drugs Tied to ...
Existing treatments for Parkinson's disease offer only symptomatic relief. Prolonged use of certain dopamine precursor drugs has diminishing returns and long-term complications such as involuntary ...
A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The research was conducted ...
Summary: The Parkinson’s drug entacapone disrupts the gut microbiome by inducing iron deficiency, favoring the growth of potentially harmful bacteria like E. coli. Using advanced molecular techniques, ...
Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...
NEW YORK – Gain Therapeutics is exploring whether a drug targeting the enzyme glucocerebrosidase, or GCase, could treat Parkinson's disease not only for patients with certain mutations in the gene ...
The Vyafuser pump maintains a continuous, steady flow of the drug throughout the day and can be refilled at home by patients or their carers. "People living with advanced Parkinson's disease ...